Lysine

Lysine

SCHEMBL9716604

NCCCCC(N)C(=O)O.O=C(O)CNc1ccccc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.57
▸ MMP2 P08253 2/20 0.47
▸ LTA4H P09960 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ DPP7 Q9UHL4 2/20 0.45
▸ DPP8 Q6V1X1 1/20 0.45
▸ DPP9 Q86TI2 1/20 0.45
▸ THRB P10828 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ KIF11 P52732 3/20 0.41
▸ ARG2 P78540 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL941017 1.00 GSR (0.57) GSRMMP2LTA4HPOLBKMT2A
Ornithine Aketoglutarate SCHEMBL15539555 0.96 GSR (0.50) GSRMMP2LTA4HPOLBKMT2A
Diphenylamine SCHEMBL593267 0.86 GSR (0.67) GSRMMP2LTA4HPOLBKMT2A
Ornithine Aketoglutarate SCHEMBL11031186 0.84 GSR (0.47) GSRLTA4HPOLBKMT2ATDP1
Ornithine SCHEMBL11031187 0.84 GSR (0.47) GSRLTA4HPOLBKMT2ATDP1
Lysine SCHEMBL2473830 0.82 GSR (0.49) GSRMMP2LTA4HPOLBKMT2A
Lysine SCHEMBL22684870 0.81 GSR (0.54) GSRMMP2LTA4HPOLBKMT2A
Lysine SCHEMBL4305051 0.80 GSR (0.57) GSRMMP2LTA4HPOLBKMT2A
Lysine SCHEMBL28214073 0.79 GSR (0.91) GSRMMP2POLBKMT2ATDP1
Cysteine SCHEMBL4970300 0.79 PTGS1 (0.52) MMP2LTA4HKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591369-B2 Alpha(v)beta(6) integrin-binding peptides and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-02-28 — — US disclosed
US-20210340181-A1 ALPHA(V)BETA(6) INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-11-04 — — US disclosed
EP-3846858-A1 ALPHA(V)BETA(6) INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF The Regents of the University of California (US) 2021-07-14 — — EP disclosed
EP-0178911-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1992-01-22 — — EP disclosed
EP-0178911-A2 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1986-04-23 — — EP disclosed
Send feedback